• Yujin Lee, Shinn Won Lim, Soo Yeon Kim, Jae Won Chung, Jinwoo Kim, Woojae Myung, Jihae Song, Seonwoo Kim, Bernard J Carroll, and Doh Kwan Kim.
• Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
• Psychiat Invest. 2013 Mar 1; 10 (1): 56-61.

ObjectiveBoth clinical and biological factors influence the course of depressive disorders. This study tested for associations between the brain-derived neurotrophic factor (BDNF) gene at the Val66Met locus and the course of major depressive disorder (MDD).MethodsThree hundred ten Korean subjects (209 patients, 101 controls) were genotyped for rs6265 at nucleotide 196 (G/A), which produces an amino acid substitution at codon 66 (Val66Met) of the gene for BDNF. Course of illness was evaluated both by chronicity of current episode (episode duration >24 months) and by the lifetime history of recurrences.ResultsPatients with the Met/Met BDNF genotype had a significantly higher rate of chronic depression than all others. There was a significant dose effect of the Met allele on chronicity. Compared with the Val/Val genotype, the relative risk of chronicity was 1.67 for the Val/Met genotype, and 2.58 for the Met/Met genotype. Lifetime history of recurrent episodes was not related to BDNF genotypes but was significantly associated with younger age of onset and with a history of depression in first degree relatives.ConclusionBDNF genotyping may be informative for anticipating chronicity in major depression.

6 keywords...

hide…